REVIAN Clinical Trial Results:
“MODULATED LIGHT THERAPY IN PARTICIPANTS WITH PATTERN HAIR LOSS”
Participants who were treated with the red light therapy and were at least 80% compliant for the duration of the study (n=20) had an average of 21.3 more hairs per cm² compared to those who wore a similar cap but did not have light therapy after 16 weeks (n=20). Subjects treated with placebo continued to lose hair over the duration of the study.
REVIAN RED CAP
Primary Endpoint: Target Area Hair Counts at Week 16
Mean results shown for the Efficacy Evaluable Population of trial participants who completed all 16 weeks, had no major protocol violations, and who were at least 80% compliant with the treatment regimen for the duration of the trial.
For full trial information, see ClinicalTrials.gov : NCT04019795
1. REV-01 Data on File. A multicenter, double-blind, placebo controlled study was conducted enrolling both men and women ages 18 and older
with androgenetic alopecia. Participants were randomized to wear either the REVIAN RED cap or a Placebo Cap (no red light) for 10 minutes
per day. Approximately half of the subjects had treatment with REVIAN RED light therapy; and half did not. Total hair counts were obtained
from computer assisted scans of digital photographs taken of a defined target area (1 cm 2 ) centered around a tattoo located in the anterior mid
area of the scalp. ClinicalTrials.gov Identifier: NCT04019795.
2. Jimenez et al. Efﬁcacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study. American Journal of Clinical Dermatology 2014. PubMed Reference.
3. Olsen et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus
placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology 2007. PubMed Reference.
4. Leyden et al. Finasteride in the treatment of men with frontal male pattern hair loss. Journal of the American Academy of Dermatology
1999. PubMed Reference.